🇺🇸 FDA
Patent

US 11931463

All-in-one fixed-dose combination for treating Helicobacter pylori infection

granted A61KA61K31/395A61K31/43

Quick answer

US patent 11931463 (All-in-one fixed-dose combination for treating Helicobacter pylori infection) held by RedHill Biopharma Ltd. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RedHill Biopharma Ltd.
Grant date
Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/395, A61K31/43, A61K31/435, A61K31/438